Neusoft Medical Systems supplies CT MRI ultrasound and enterprise imaging software for hospitals and clinics.
CT scanners MRI systems ultrasound platforms and PACS solutions.
Local manufacturing capabilities flexible solutions and regional support in multiple markets.
Offers clinical training maintenance contracts and spare parts logistics.
Pelvic imaging includes ultrasound CT and MRI for gynecologic urologic and oncologic indications. It evaluates masses pain and trauma. Imaging guides biopsy and surgical planning.
Ultrasound is first line for ovarian and uterine pathology. MRI provides detailed characterization of complex adnexal masses. Imaging supports fertility and oncologic management.
CT and ultrasound assess renal and bladder pathology and stones. MRI evaluates prostate and pelvic soft tissue lesions. Imaging guides intervention and surveillance.
Cross sectional imaging stages pelvic malignancies and assesses nodal involvement. PET CT may detect metastatic disease in selected cases. Multidisciplinary review informs treatment planning.
Imaging guided biopsy obtains tissue for diagnosis of breast lesions. Techniques include ultrasound stereotactic and MRI guided approaches. Accurate targeting reduces sampling error and improves diagnosis.
Ultrasound guided biopsy is real time and widely available. It is used for lesions visible on ultrasound and allows immediate sampling. Local anesthesia and core needle techniques provide diagnostic tissue.
Stereotactic biopsy uses mammographic localization for non palpable lesions. It is effective for microcalcifications and subtle mammographic findings. Compression and targeting ensure accurate sampling.
MRI guided biopsy targets lesions seen only on MRI and not on other modalities. It requires specialized equipment and expertise. MRI guidance expands diagnostic options for complex cases.
Liver imaging includes ultrasound CT and MRI for lesion detection and characterization. Multiphasic contrast protocols improve detection of hepatocellular carcinoma. Imaging guides biopsy and treatment planning.
Ultrasound is the first line tool for screening and surveillance of liver disease. It detects focal lesions and steatosis and guides biopsy. Elastography assesses fibrosis non invasively.
CT and MRI provide detailed lesion characterization and staging. MRI offers superior soft tissue contrast and functional sequences. Contrast timing is critical for lesion detection.
Imaging guides ablation embolization and biopsy procedures. Image guidance improves targeting and safety. Multidisciplinary care integrates imaging with oncology and surgery.
Fetal imaging uses ultrasound as the primary modality for prenatal assessment. MRI provides additional detail for complex anomalies and brain development. Imaging informs counseling and perinatal planning.
Ultrasound evaluates fetal growth anatomy and placental position. Doppler assesses fetal circulation and wellbeing. Serial studies monitor growth and development.
Fetal MRI offers superior soft tissue contrast for brain and thoracic anomalies. It is used when ultrasound findings are inconclusive or complex. MRI does not use ionizing radiation and is safe in pregnancy.
Imaging findings guide multidisciplinary counseling and delivery planning. Follow up imaging monitors progression and response to interventions. Coordination with maternal fetal medicine ensures comprehensive care.
Ophthalmic imaging includes fundus photography optical coherence tomography and ultrasound. It evaluates retinal and optic nerve pathology. Imaging guides diagnosis and treatment of ocular disease.
OCT provides high resolution cross sectional images of the retina. It is essential for macular disease and glaucoma assessment. Quantitative metrics support monitoring and therapy decisions.
Ocular ultrasound evaluates vitreous and retinal detachment and tumors. MRI assesses orbital masses and optic nerve pathology. Imaging complements clinical ophthalmic examination.
Digital imaging enables remote screening and monitoring of eye disease. Teleophthalmology expands access to diabetic retinopathy screening. Secure image transfer and standardized reporting support programs.
Contrast media enhance visualization of vascular and tissue structures. They include iodinated agents gadolinium based agents and ultrasound contrast. Selection depends on modality and clinical question.
Allergic and idiosyncratic reactions can occur with contrast agents. Screening for risk factors and premedication protocols reduce adverse events. Hydration and renal function assessment are important for iodinated agents.
Contrast dosing and timing affect lesion conspicuity and diagnostic yield. Protocols are tailored to organ system and clinical indication. Optimization balances image quality and patient safety.
New contrast agents target molecular markers and improve specificity. Lower dose formulations and alternative agents reduce risk. Research explores targeted and theranostic contrast approaches.
Breast imaging includes mammography ultrasound and MRI. It evaluates screening and diagnostic concerns. Multimodality assessment improves diagnostic accuracy.
Risk assessment guides screening frequency and modality selection. Family history and genetic testing inform management. Personalized screening improves early detection.
Imaging guided biopsy uses ultrasound stereotactic or MRI guidance. Accurate targeting ensures diagnostic tissue sampling. Post biopsy imaging documents results and complications.
Surveillance imaging monitors high risk patients and treated cancers. It includes periodic mammography and adjunct modalities as needed. Coordination with oncology ensures comprehensive care.
Sports imaging focuses on rapid accurate assessment of musculoskeletal injuries to guide return to play decisions. Modalities include MRI ultrasound and radiography. Imaging supports prevention rehabilitation and performance optimization.
MRI is the gold standard for soft tissue injury evaluation including ligament and tendon tears. Ultrasound provides dynamic assessment and procedural guidance for injections. Timely imaging informs management and prognosis.
Imaging detects stress reactions tendinopathy and cartilage wear in athletes. Advanced MRI techniques assess early cartilage and bone changes. Imaging guides load management and targeted therapies.
Imaging findings are integrated with clinical assessment and functional testing for return to play decisions. Clear communication with sports medicine teams ensures athlete safety. Serial imaging monitors healing and guides rehabilitation.
Imaging assists in planning cosmetic and reconstructive procedures by defining anatomy and tissue characteristics. Modalities include ultrasound CT MRI and 3D surface imaging. Imaging improves precision and patient counseling.
3D surface imaging and CT provide detailed assessment for facial reconstruction and implants. Imaging helps simulate outcomes and plan osteotomies and grafting. Integration with surgical navigation enhances accuracy.
Imaging evaluates implant position integrity and capsular contracture. Ultrasound and MRI assess implant complications and guide revision surgery. Preoperative imaging informs implant selection and placement.
CT and ultrasound assess fat distribution and vascular anatomy for planning procedures. Imaging supports safe liposuction and flap based reconstructions. Postoperative imaging monitors complications and outcomes.
